Evidence map›Paper›PMID 15574194›Full record

ArticleMolecular cancer2004

Mitochondrial inhibition of uracil-DNA glycosylase is not mutagenic.

Sushant Kachhap, Keshav K Singh

Open access · goldAbstract read
In one paragraph

Article in Molecular cancer, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 7 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Sushant KachhapSidney Kimmel Cancer Center, Johns Hopkins School of Medicine, Bunting-Blaustein Cancer Research Building, 1650 Orleans St., Baltimore, MD 21231, USA. sushantkk@yahoo.com <sushantkk@yahoo.com>
Keshav K Singh
Cancer Genetics (United States) · USSidney Kimmel Cancer Center · US

Funding

PHS HHS R01-097714
6 · The paper itself

Abstract

backgroundUracil DNA glycosylase (UDG) plays a major role in repair of uracil formed due to deamination of cytosine. UDG in human cells is present in both the nucleus and mitochondrial compartments. Although, UDG's role in the nucleus is well established its role in mitochondria is less clear.

resultsIn order to identify UDG's role in the mitochondria we expressed UGI (uracil glycosylase inhibitor) a natural inhibitor of UDG in the mitochondria. Our studies suggest that inhibition of UDG by UGI in the mitochondria does not lead to either spontaneous or induced mutations in mtDNA. Our studies also suggest that UGI expression has no affect on cellular growth or cytochrome c-oxidase activity.

conclusionsThese results suggest that human cell mitochondria contain alternatives glycosylase (s) that may function as back up DNA repair protein (s) that repair uracil in the mitochondria.

Indexed as

BreastCell LineCell ProliferationDNA GlycosylasesDNA, MitochondrialDNA RepairEpithelial CellsHumansMembrane ProteinsMitochondriaMutationProstaglandin-Endoperoxide SynthasesTransfectionUracilUracil-DNA GlycosidaseViral ProteinsDNA GlycosylasesDNA, MitochondrialMembrane ProteinsProstaglandin-Endoperoxide SynthasesUracilUracil-DNA Glycosidaseuracil-DNA glycosylase inhibitor protein, B. subtilis bacteriophageViral Proteins

Identifiers

PMID15574194
PMCPMC538255
OpenAlexW2156872707

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.